
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sub C gp140 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sub C gp140 Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of HIV Infections.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
June 20, 2011
Lead Product(s) : Sub C gp140 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Recipient : National Institute of Allergy and Infectious Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
